ing the beneficial effects of levodopa. The subthalamic nucleus (STN) is considered to play a pivotal role in the pathophysiology of PD and LID. Some patients with PD have seen their parkinsonian symptoms alleviated after a coincidental infarction in the STN. 147, 174, 190 Subthalamic lesioning (subthalamotomy) performed in parkinsonian monkeys demonstrated promising results. 17, 18, 23, 64 Nowadays, the STN is one of the major targets of stereotactic lesioning and deep brain stimulation (DBS) for the treatment of movement disorders. 53 Despite surgical interest in the STN, few reviews cover subthalamotomy as a treatment of PD. 59, 65, 121 The present study reviews the clinical aspects and complications of subthalamotomy in the treatment of PD. Subthalamotomy is compared with other surgical treatments, and a discussion is provided on the possible mechanisms involved in the beneficial motor effects of subthalamic lesions.
History of Subthalamotomy
Historically, lesioning the STN has been avoided for fear of inducing hemiballismus. In fact, it has been known since the end of the 19th century that STN lesions provoked hemiballismus as observed in patients with PD who have suffered a stroke. 34 It was demonstrated that lesions Subthalamotomy in the treatment of Parkinson's disease: clinical aspects and mechanisms of action confined to the STN in normal monkeys were at high risk for hemiballismus, 35, 184 and destruction of 20% of the STN's volume was enough to provoke this involuntary movement. 35 The development of hemiballismus in normal monkeys was confirmed in nonparkinsonian patients following lesioning restricted to the STN. 46, 104, 108, 118 Nevertheless, several authors performed so-called subthalamotomies for PD, giving rise to a great wealth of publications in the 1960s and 1970s. 13, 74, 102, 146 During the lesioning era, the target for subthalamotomy was not the STN as it is today. In fact, authors performed their lesioning in the zona incerta (Zi), 14, 112, 113 the subventrolateral thalamus, 116 the posterior subthalamic area, and the Raprl (prelemniscal radiations) 24, 75, 82, 173 or H 2 Field of Forel (lenticular fasciculus), 14, 76, 77, 106, 113, 154, 155 all under the term "subthalamotomy," while others coined the term "campotomy." 152 However, none of these authors targeted the STN itself. Instead, lesions were made in the subthalamic area, mainly in the fiber bundles. As pointed out by Spiegel et al., 152 the advantage of targeting the pallidothalamic fibers is that a smaller lesion is needed to obtain clinical results than when targeting the globus pallidus internus (GPi). On the other hand, since precise imaging and electrophysiological data were scarce, if not completely lacking at that time, it is difficult to compare these publications with current subthalamotomy knowledge. In the 1960s and 1970s, lesioning in the subthalamic area was not restricted to PD treatment, but was also used for the treatment of tremor, 82, 173 cerebral palsy, 82, 94 and hyperkinetic movements, 116 including dystonia, 155 intractable spasms, 82, 155 athetosis, 119, 155 hemiballismus, 11, 12 and dyskinesia.
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Clinical Outcome of Subthalamotomy
Parkinsonian Symptoms
The last 2 decades have seen many studies addressing the motor 5, 16, 20, 47, 57, 58, 99, 109, 120, 129, 168, 176 and cognitive 7, 25, 105 effects of subthalamotomy for PD (Table 1) ; there have also been several case reports. 38, 45, 72, 87, 122 A recollection of studies indicates that subthalamotomies have beneficial effects on the motor symptoms in both off-and on-medication states with better results from bilateral lesions. The surgery significantly reduces contralateral cardinal symptoms (tremor, bradykinesia, and rigidity).
8, 130 The improvements obtained with unilateral lesions seemed to increase in the first 12 months and to decrease in the 2nd year after surgery (see the averages in Table 1 ). Small benefits were also observed ipsilateral to STN lesions but did not last for more than 1 year.
8,130,161
Effects on Levodopa Needs and LID
Dyskinesias, assessed using the Unified Parkinson's Disease Rating Scale (UPDRS) Part IV, are highly improved by both unilateral and bilateral STN lesions (Table  1) . A striking feature is the consistency of improvement in LID over the first 2 years, where a steady 65% reduction is observed (see the averages in Table 1 ). Contralateral diphasic dyskinesias and off-medication dystonia seem to respond best to subthalamotomy, whereas peak-dose dyskinesias remain unchanged.
8 Furthermore, ipsilateral LIDs are unresponsive to STN lesions.
8 It is usually assumed that the reduction of LIDs is the result of reduced levodopa equivalency daily doses (LEDDs) after altering STN activity. 91 One and 2 years after subthalamotomy, the LEDD was reduced by approximately 45% and 30%, respectively. The progression of the disease may, in part, explain the diminishing improvements in motor and levodopa needs.
8 Nevertheless, the reduction in LEDD cannot be the sole explanation of the improvements in LIDs for 2 main reasons. First, the mean reduction in LIDs remained constant despite LEDD changes over a 2-year period. Second, ipsilateral LIDs continued to increase even if levodopa was greatly reduced. Another interesting feature of subthalamotomy is the potentiation of response to levodopa. It was reported that the on-time duration without significant dyskinesia increased 4-fold when the medication was halved. 130 Daily off-time periods were reduced from 50% to near abolition in the 1st year.
6, 68, 130, 160 Lesions created by the insertion of microelectrode probes or DBS electrodes were found to have positive effects on parkinsonian symptoms peri-and postoperatively. 100, 101, 135, 152, 189 This observation provided evidence to the knowledge that small and confined STN inactivation can be sufficient to produce an improvement of PD, as replicated in animal models. 21 These so-called microlesions appear to have similar effects on the metabolic activity of the globus pallidus, the striatum, the thalamus, and the cortex as those measured after subthalamotomy, but to a lesser extent.
135,157,168
Cognitive Outcome
Surgical procedures in the basal ganglia can potentially induce neuropsychological impairments, as observed after bilateral pallidotomy or subthalamic DBS. 43, 156 Contrary to this, subthalamotomy has not been shown to cause major cognitive impairment. 105, 130 In fact, no studies using a cognitive test (mini-mental state examination) observed a decline after unilateral or bilateral lesions. 7, 8, 25, 110, 170 Slight improvements in verbal fluency, as well as decreases in dementia, apathy, and depression were seen in patients. 7, 8 A recent study demonstrated decreased attention, inhibition, and verbal learning in up to 30% of the patients, but these did not affect patients globally. 105 Finally, executive functions and memory remained unaffected by STN lesions.
41,105
Subthalamotomy Versus Other Surgical Treatments
According to the recent review of evidence-based medicine for the treatment of the motor symptoms of PD by the Movement Disorders Society, 54 unilateral pallidotomy and bilateral GPi or STN DBS were found effective for motor complications of PD. Unilateral posteroventral pallidotomy is known to result in 20%-35% improvement in off-medication motor symptoms during the first 2 years after surgery. 69 In a randomized controlled trial (RCT) comparing unilateral pallidotomy with medical therapy, contralateral dyskinesias were reduced by 75% and 78% at 6 and 24 months postpallidotomy, respectively, and re-mained unchanged with medical therapy. 177 In the same study by Vitek et al., ipsilateral dyskinesias were also improved significantly. However, levodopa needs remained the same after 6 months (0.4% decrease in pallidotomy and 7.1% increase with the medical therapy only).
Bilateral subthalamic DBS is assumed to be the most widely used surgical procedure for PD treatment.
1, 85, 145 In a recent 6-month RCT, bilateral STN DBS was compared with the best medical therapy. 182 It was demonstrated that off-medication motor symptoms were improved by 28.6% and remained unchanged with medical therapy. Similar results were obtained for motor complications (36.9% vs 5.4% for STN DBS and medical therapy, respectively). Levodopa equivalencies were reduced by 23.1% after 6 months of STN DBS, whereas they increased insignificantly (1.1%) with the best medical therapy.
Subthalamotomy is still regarded as an experimental procedure for PD. 54, 165 Paradoxically, a recent study demonstrated that neurosurgeons performed subthalamotomies as often as pallidotomies or thalamotomies in most or all of their cases. 85, 145 It was shown that lesioning was more often offered to patients in countries with lower economical development or when patients financed their own surgeries. Subthalamotomy was not included in the rec- ommended procedures for motor complications because of insufficient evidence. Two studies 41, 110 met Level I criteria, depicted by at least 1 high-quality RCT, but these studies were not included in the review because of their small sample sizes. In the first study, 41 unilateral subthalamotomy was compared with unilateral pallidotomy and bilateral STN DBS. The authors concluded that both procedures offered major motor improvement and that these 2 surgeries were equally effective for the motor treatment of PD. Also, they observed that unilateral subthalamotomy had the advantage of reducing levodopa needs, whereas the needs remained unchanged with unilateral pallidotomy. 41 In the second RCT comparing bilateral subthalamotomy and bilateral STN DBS, the 2 surgical procedures had similar benefits on motor symptoms in patients with PD and the results were comparable to previous literature. 110 Although these 2 RCTs provided evidence on the positive effects of STN lesions, larger RCTs are warranted to fully assess the cost-effectiveness and the role of subthalamotomy in the treatment of PD.
The tremendous improvements and low complications profile observed in patients treated with DBS are obvious reasons for its vast use worldwide. 22 However, STN lesioning may be an alternative when DBS is not a possible treatment for certain reasons, such as access to care and health status. 73 Lesion therapies are much less expensive than DBS. 50 In fact, the direct and indirect costs of a DBS system 153 outrun lesion-based costs. Moreover, patients have shorter hospital stays after lesioning than those who receive DBS implants. 50 Subthalamotomy also presents advantages that are not seen with other lesioning treatments. Patients undergoing unilateral subthalamotomy seem to respond as well as those undergoing unilateral pallidotomy when considering motor and dyskinesia improvements. 41 Bilateral subthalamotomy does not seem to induce severe cognitive decline as seen in bilateral pallidotomy. 55 Subthalamic nucleus lesions allow for a reduction in levodopa, whereas levodopa remains practically unchanged after pallidotomy. 88 This advantage is valuable when patients have levodopa-induced hallucinations. Although there are no studies on this matter, STN DBS was recently shown to reduce hallucinations after medication adjustments 172 and could be achieved with STN lesions.
Cellular and Biochemical Effects of Subthalamotomy
Neuroprotection
There is evidence suggesting that dopaminergic cells are sensitive to excitatory glutamatergic input implicated in neurotoxicity in PD.
62 Dopaminergic cells present both N-methyl-d-aspartate (NMDA) and non-NMDA glutamate receptors, 125 and antagonizing the former receptor was shown to protect substantia nigra pars compacta (SNc) cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity. 31, 192 The STN is the main excitatory structure of the basal ganglia 151 and has efferences in the SNc. 150 It was originally hypothesized that STN overactivity in PD could contribute to progression of the disease 4, 150 and its inactivation may slow or prevent it.
In rats, most of the studies failed to demonstrate a neuroprotective effect of previous STN lesions before large exposure to the neurotoxin 6-hydroxydopamine (6-OHDA) on dopaminergic cells survival. 115, 131, 140 It was, however, shown that the phenotype, measured by tyrosine hydroxylase immunohistochemistry, the rate-limiting enzyme in the production of dopamine synthesis, was preserved in the surviving cells in the first weeks after exposure to 6-OHDA. 36, 131, 187 On the contrary, some authors observed neuroprotection in rats with small dopamine depletion, 133 but its effectiveness decreased in a time-dependent manner and was no longer detected after 1 week.
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In primates, a recent study showed the neuroprotective effects of dopaminergic cells, when subthalamotomy is performed 2 weeks before or 1 week after MPTP insult. 181 More recently, we observed no changes in tyrosine hydroxylase-positive immunohistochemistry or in dopamine or its metabolite concentrations after unilateral subthalamotomy. 86 This discrepancy might be explained by the same 3 main factors seen in rodents: the extent of dopamine depletion, the extent of the STN lesion, and the time between the 2 insults. The dopaminergic denervation was much more profound in our monkeys than it was in the study by Wallace and colleagues. 181 Monkeys in that study had 50% dopaminergic loss in the SNc, whereas monkeys in our study had a near complete loss. Neuroprotective effects of STN alteration are inversely proportional to the extent of the MPTP insult. A study in MPTP-injected monkeys failed to show neuroprotection with 85% of dopaminergic loss. 98 The survival time between MPTP administration and subthalamotomy is also likely to explain the difference. In the study by Wallace et al., monkeys received a subthalamotomy only 6 days after MPTP and were killed roughly 14 days after lesioning, 181 whereas the monkeys in our previous study were rendered parkinsonian many years before the STN lesion and were killed several weeks after surgery. Lastly, the STN is not the only glutamatergic source to the SNc. In fact, the latter receives excitatory input from the pedunculopontine nu cleus (PPN) and the cortex 93, 95 and may also contribute to the glutamate-mediated excitotoxicity. 164 Clinically, PD cardinal symptoms appear after 80% of striatal dopaminergic loss, 167 and patients with PD undergo surgery when their disease becomes pharmacologically refractive to levodopa or when LIDs are disabling. Thus, neuroprotective studies do not reflect surgical practices in a clinical perspective and clearly cannot be applied in a clinical context.
Neurophysiology
Subthalamic nucleus activity in PD is known to increase in frequency and to increase burst firing. 137 In humans and primates, similar changes were observed in the STN output nuclei, that is, the GPi and substantia nigra pars reticulata (SNr). Globus pallidus internus neuronal activity increases from 60-70 Hz in the normal state 163, 186 to 70-85 Hz in PD 78, 97 and from 60 to 70 Hz in the SNr. 79, 186 The administration of levodopa not only reverses these increases but also tends to further reduce the basal activity of the GPi and SNr. 30, 60, 70, 78, 97, 124 exerts comparable effects by restoring normal electrophysiological activity. Subthalamic nucleus lesions decreased the GPi firing rate in normal monkeys 66 and reversed the increased GPi neuronal activity induced by 6-OHDA in rats.
117 Some authors observed only that the GPi firing pattern returned to normal, resulting mainly in reduced burst firing without any change in firing rate. 144 However, the MPTP-induced GPi oscillations persisted in parkinsonian monkeys. 185 Similarly, SNr electrical activity was also decreased after subthalamotomy in normal 191 and 6-OHDA rats 32,127,144 with reduced burst firing. 114, 171 Moreover, the 6-OHDA-induced increase in the PPN firing rate was prevented with STN lesions in rats, but no change was observed in normal rats after STN destruction. 84 On the contrary, subthalamotomy in normal rats increased the number of PPN neurons that displayed bursting activity by more than 30%, whereas 6-OHDA lesions with or without STN lesions increased the number by only 8%-12%. 84 These last 2 observations indicate that the changes in PPN activity following STN lesioning are not due to a direct subthalamo-pedunculopontine connection. Lastly, SNc neurons were also observed to reduce their firing rate and their burst activity after STN lesioning, 26, 148, 149 but those findings were not replicated by others.
191 Thus, it is generally agreed that subthalamotomy decreases neuronal activities in GPi, SNr, and SNc, which is consistent with the fact that STN exerts an excitatory input on these structures.
Neurochemistry
The consequences of these physiological changes in STN output translate into measurable biochemical modifications (Table 2) . Reductions in cytochrome oxidase and succinate hydrogenase, both markers of cellular activities, were found in the GPi and SNr after STN lesioning in normal and 6-OHDA rats, 27,28,132 corroborating the decrease in firing rates and patterns. Messenger RNA of enzyme glutamic acid decarboxylase (GAD 67 )-which is needed for the conversion of glutamate to g-aminobutyric acid present in the globus pallidus externus (GPe), GPi, and SNr-also decreases with subthalamotomy in MPTP monkeys and 6-OHDA rats. 44, 132 This indicates that these cells are less active and consume less energy after subthalamotomy. 111 However, increases in GAD 67 levels were observed in the GPi and GPe of normal monkeys after STN lesions. 10 As for the changes in the SNc electrophysiology, some studies reported increased striatal dopamine and tyrosine hydroxylase positivity, 10,80 and others reported a reduction. 148 
Subthalamotomy Complications
Hemiballismus Subthalamic nucleus lesions have been known to induce hemiballismus, which is the violent, irregular, and involuntary movement of one half of the body. 134 Hemiballismus is usually observed contralateral to STN lesions in patients with PD (Table 3) , but ipsilateral hemiballismus was also described secondary to STN infarct or hemorrhage in nonparkinsonian patients. 42, 92, 138 Hemiballismus has many causes and may be caused by lesions in the STN, but also by lesions in other structures of the basal ganglia.
46,56,61,139, 174 In patients with PD who undergo subthalamotomy, transient hemiballismus (< 1 year) was observed in 13.2% (40 of 303 patients enrolled in studies or case reports) with spontaneous recovery or with successful pharmacological treatment, whereas it remained permanent in 9.9% (includes 2 patients receiving ipsilateral thalamotomy during the same surgical procedure since they presented with hemiballismus/hemichorea by the end of STN surgery 175, 176 ). It has been suggested that smaller lesions would allow for compensatory mechanisms within the basal ganglia, tending to reestablish equilibrium and cease hemiballismus. Conversely, in larger STN lesions, a persistent decrease in GPi and SNr activities was observed. 169 Recently, 2 cases were described in which transient hemiballismus was the result of a small hemorrhage or an infarct in the STN. 118 Both patients recovered within 4 weeks after the symptoms appeared, without any pharmacological or surgical treatment, supporting this hypothesis. Other authors have suggested that lesions confined to the nucleus were more prone to induce hemiballismus and lesions extending its boundaries could prevent the development of hemiballismus by reducing pallidothalamic outflow.
39, 49 This hypothesis is supported by the fact that pallidotomies can completely abolish hemiballismus in patients with PD. 162 Finally, hemiballismus is not strictly caused by STN lesions. It was also observed in patients with PD after thalamotomy 48 and subthalamic DBS.
90,123
Although these 2 hypotheses (size and location of the lesion) neither exclude nor invalidate one another, 184 the underlying mechanisms of hemiballismus after subthalamotomy have yet to be clarified.
Postural Disturbance
Patients with PD may present with postural abnormalities such as neck flexion and camptocormia. 83 Patients with postural asymmetry show lateral curvature of the spine with an inclination of the trunk toward the ipsilateral side that is more depleted in dopamine. This instability of posture responds poorly to levodopa. 103 Similar postural asymmetry was observed after STN lesioning in nonparkinsonian 104 and PD patients. 102, 159 These patients displayed a body tilt contralateral to the lesion accompanied by head rotation. Head rotations were seen in normal and parkinsonian monkeys in which the STN was lesioned.
10,33,67,71 It was proposed that an imbalance of the dopaminergic influence between the lesioned and nonlesioned hemispheres 159 and/or the glutamatergic imbalance between the STN and the SNr may occur. 86 Finally, transient postural disturbance was also reported after unilateral and bilateral subthalamotomy.
110,175
Other Complications
In the series by Alvarez and colleagues 8 consisting of 89 patients undergoing unilateral subthalamotomy, some patients presented with transient dysarthria, infection of the scalp, asymptomatic bleeding, and seizures. All of these complications were observed in less than 5% of patients. Speech and dysarthria complications were seen in 3 patients undergoing bilateral STN lesioning. Two of these patients also displayed trunk and gait ataxia.
8 Ataxia was associated with larger lesions in those patients.
7 Subthalamic nucleus lesions were also shown to induce blepha-rospasm or ptosis in healthy individuals, 126 as well as in PD 143 or dystonic patients 89 undergoing subthalamotomy to alleviate their symptoms. Finally, neuropsychiatric side effects were also associated with STN alterations, such as hyperphagia, 51 hypersexuality, 2 and impulse behavior.
2,126
Conclusions
The STN plays a pivotal role in the basal ganglia, since it is connected to many other structures within the basal ganglia and to nuclei outside of it. It is widely ac- 6-OHDA complete loss near complete reverses the increased striatal enkephalin mRNA levels in 6-OHDA rats; reverses the increased GAD 67 mRNA levels in 6-OHDA rats in the EN & SNr; no effect on the decreased levels of substance P mRNA in 6-OHDA rats Blandini et al. normal none >50% loss ↓ striatal dopamine * AMPA = α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CM/Pf = centromedian and parafascicular thalamic nuclei; CO = cytochrome oxidase; DA = dopamine; DAT = dopamine transporter; EN = entopeduncular nucleus, rat homolog of the primate GPe; GABA = g-aminobutyric acid; GP = rat globus pallidus, homolog of the primate GPi; HVA = homovanillic acid; NA: not available; SDH = succinate dehydrogenase; TH = tyrosine hydroxylase; VA/VL = ventroanterior and ventrolateral thalamic nuclei; ↑ = increases; ↓ = decreases.
cepted that its overactivity in patients with PD is one of the pathophysiological causes underlying the cardinal symptoms of PD and dyskinesias. Despite the fact that the STN is the main target for DBS in patients with PD, subthalamotomy remains an alternative surgical option for patients whose conditions are refractory to pharmacological treatment or those who are unable to receive DBS implants due to medical reasons or access limitations. Several studies demonstrated the effectiveness of subthalamotomy in the treatment of PD. It reduces daily levodopa needs and was associated with few, mainly transient, complications. Nevertheless, more clinical evidence is needed to warrant its use as a treatment option for PD.
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